Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lurasidone Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102952001A offers cost-effective chiral intermediate production. Enhances supply chain reliability for Lurasidone manufacturing.
Patent CN104513182A details a safer synthetic route for Lurasidone intermediates offering enhanced supply chain stability and reduced toxic waste for global pharmaceutical manufacturers.